Works matching DE "MESOTHELIN"

Results: 99

The Potential of CAR T Cell Therapy in Pancreatic Cancer.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02166

By:

Akce, Mehmet;
Zaidi, Mohammad Y.;
Waller, Edmund K.;
El-Rayes, Bassel F.;
Lesinski, Gregory B.

Publication type:

Article

Validity of mesothelin in occupational medicine practice.

Published in:

2016

By:

Taeger, Dirk;
Gawrych, Katarzyna;
Brüning, Thomas

Publication type:

Letter

Response to the letter to editors concerning "Validity of mesothelin in occupational medicine practice".

Published in:

2016

By:

Smolková, Petra;
Nakládalová, Marie;
Zapletalová2, Jana;
Zapletalová, Jana

Publication type:

journal article

Mesothelin as a Signal Pathways and Epigenetic Target in Cancer Therapy.

Published in:

Cancers, 2025, v. 17, n. 7, p. 1118, doi. 10.3390/cancers17071118

By:

Kumari, Seema

Publication type:

Article

Radiomics-Based Prediction of Treatment Response to TRuC-T Cell Therapy in Patients with Mesothelioma: A Pilot Study.

Published in:

Cancers, 2025, v. 17, n. 3, p. 463, doi. 10.3390/cancers17030463

By:

Beaumont, Hubert;
Iannessi, Antoine;
Thinnes, Alexandre;
Jacques, Sebastien;
Quintás-Cardama, Alfonso

Publication type:

Article

Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas.

Published in:

Cancers, 2024, v. 16, n. 15, p. 2697, doi. 10.3390/cancers16152697

By:

Tomero-Sanz, Henar;
Jiménez-Heffernan, José Antonio;
Fernández-Chacón, María Concepción;
Cristóbal-García, Ignacio;
Sainz de la Cuesta, Ricardo;
González-Cortijo, Lucía;
López-Cabrera, Manuel;
Sandoval, Pilar

Publication type:

Article

Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma.

Published in:

Cancers, 2024, v. 16, n. 7, p. 1252, doi. 10.3390/cancers16071252

By:

Yun, Karen M.;
Bazhenova, Lyudmila

Publication type:

Article

Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.

Published in:

Cancers, 2023, v. 15, n. 23, p. 5694, doi. 10.3390/cancers15235694

By:

Rodriguez, Galaxia M.;
Yakubovich, Edward;
Vanderhyden, Barbara C.

Publication type:

Article

Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adenocarcinoma.

Published in:

Cancers, 2023, v. 15, n. 18, p. 4586, doi. 10.3390/cancers15184586

By:

Nicoletti, Alberto;
Vitale, Federica;
Quero, Giuseppe;
Paratore, Mattia;
Fiorillo, Claudio;
Negri, Marcantonio;
Carlino, Angela;
Inzani, Frediano;
Gasbarrini, Antonio;
Alfieri, Sergio;
Zileri Dal Verme, Lorenzo

Publication type:

Article

Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer.

Published in:

Cancers, 2023, v. 15, n. 13, p. 3397, doi. 10.3390/cancers15133397

By:

Grašič Kuhar, Cvetka;
Silvester, Jernej;
Mencinger, Marina;
Ovčariček, Tanja;
Čemažar, Maja;
Miceska, Simona;
Modic, Živa;
Kuhar, Anamarija;
Jesenko, Tanja;
Kloboves Prevodnik, Veronika

Publication type:

Article

Challenges of Anti-Mesothelin CAR-T-Cell Therapy.

Published in:

Cancers, 2023, v. 15, n. 5, p. 1357, doi. 10.3390/cancers15051357

By:

Zhai, Xuejia;
Mao, Ling;
Wu, Min;
Liu, Jie;
Yu, Shicang

Publication type:

Article

Metastases to Meningiomas: A Comprehensive Literature Review Including Mediating Proteins.

Published in:

Cancers, 2022, v. 14, n. 23, p. 5877, doi. 10.3390/cancers14235877

By:

Johnson, Mahlon D.

Publication type:

Article

The Role of Mesothelin Expression in Serous Ovarian Carcinoma: Impacts on Diagnosis, Prognosis, and Therapeutic Targets.

Published in:

Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092283

By:

Giordano, Giovanna;
Ferioli, Elena;
Tafuni, Alessandro

Publication type:

Article

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients.

Published in:

Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092260

By:

Tegeler, Christian M.;
Scheid, Jonas;
Rammensee, Hans-Georg;
Salih, Helmut R.;
Walz, Juliane S.;
Heitmann, Jonas S.;
Nelde, Annika

Publication type:

Article

The Inhibitory Effects of Anti-ERC/Mesothelin Antibody 22A31 on Colorectal Adenocarcinoma Cells, within a Mouse Xenograft Model.

Published in:

Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092198

By:

Taniguchi, Gentaro;
Kajino, Kazunori;
Momose, Shuji;
Saeki, Harumi;
Yue, Liang;
Ohtsuji, Naomi;
Abe, Masaaki;
Shibuya, Tomoyoshi;
Orimo, Akira;
Nagahara, Akihito;
Watanabe, Sumio;
Hino, Okio

Publication type:

Article

Mesothelin: An Immunotherapeutic Target beyond Solid Tumors.

Published in:

Cancers, 2022, v. 14, n. 6, p. 1550, doi. 10.3390/cancers14061550

By:

Faust, Joshua R.;
Hamill, Darcy;
Kolb, Edward Anders;
Gopalakrishnapillai, Anilkumar;
Barwe, Sonali P.

Publication type:

Article

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

Published in:

Journal of Neuro-Oncology, 2016, v. 130, n. 3, p. 543, doi. 10.1007/s11060-016-2256-0

By:

Han, Seunggu;
Reis, Gerald;
Kohanbash, Gary;
Shrivastav, Shruti;
Magill, Stephen;
Molinaro, Annette;
McDermott, Michael;
Theodosopoulos, Philip;
Aghi, Manish;
Berger, Mitchel;
Butowski, Nicholas;
Barani, Igor;
Phillips, Joanna;
Perry, Arie;
Okada, Hideho

Publication type:

Article

Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.

Published in:

Pathology & Oncology Research, 2016, v. 22, n. 4, p. 725, doi. 10.1007/s12253-016-0060-y

By:

Foda, Abd;
El-Hawary, Amira;
Hamed, Hazem

Publication type:

Article

How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab.

Published in:

Journal of Immunoassay & Immunochemistry, 2018, v. 39, n. 3, p. 263, doi. 10.1080/15321819.2018.1472606

By:

Mlika, Mona;
Lamzibri, Oumeima;
Bacha, Saoussen;
Laabidi, Soumeya;
Haddouchi, Chokri;
Mezni, Faouzi El

Publication type:

Article

Tumor immunotherapy with mesothelin-targeted drugs: opportunities and challenges.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 841, doi. 10.3872/j.issn.1007-385X.2024.09.001

By:

WANG Ying;
LIU Baorui

Publication type:

Article

Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma.

Published in:

BioMed Research International, 2022, p. 1, doi. 10.1155/2022/6860510

By:

Liu, Hailin;
Yan, Bo;
Chen, Yulong;
Pang, Juan;
Li, Yue;
Zhang, Zhenfa;
Li, Chenguang;
Qin, Tingting

Publication type:

Article

Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.

Published in:

Clinical Chemistry & Laboratory Medicine, 2013, v. 51, n. 9, p. 1815, doi. 10.1515/cclm-2013-0151

By:

Bandiera, Elisabetta;
Zanotti, Laura;
Fabricio, Aline S.C.;
Bucca, Elisa;
Squarcina, Elisa;
Romani, Chiara;
Tassi, Renata;
Bignotti, Eliana;
Todeschini, Paola;
Tognon, Germana;
Romagnolo, Cesare;
Gion, Massimo;
Sartori, Enrico;
Maggino, Tiziano;
Pecorelli, Sergio;
Ravaggi, Antonella

Publication type:

Article

A predictive equation to adjust for clinical variables in soluble mesothelin-related protein (SMRP) levels.

Published in:

Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 12, p. 2199, doi. 10.1515/cclm-2012-0314

By:

Park, Eun-Kee;
Wilson, Donald;
Yates, Deborah H.

Publication type:

Article

Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers.

Published in:

Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 4, p. 721, doi. 10.1515/cclm.2011.816

By:

Sharon, Elad;
Zhang, Jingli;
Hollevoet, Kevin;
Steinberg, Seth M.;
Pastan, Ira;
Onda, Masanori;
Gaedcke, Jochen;
Ghadimi, B. Michael;
Ried, Thomas;
Hassan, Raffit

Publication type:

Article

Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2012, v. 31, n. 1, p. 1, doi. 10.1186/1756-9966-31-84

By:

Chunning Zheng;
Wei Jia;
Yong Tang;
HuiLiang Zhao;
Yingsheng Jiang;
Shaochuan Sun

Publication type:

Article

The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication.

Published in:

British Journal of Cancer, 2015, v. 112, n. 7, p. 1175, doi. 10.1038/bjc.2015.62

By:

Hooper, C E;
Lyburn, I D;
Searle, J;
Darby, M;
Hall, T;
Hall, D;
Morley, A;
White, P;
Rahman, N M;
De Winton, E;
Clive, A;
Masani, V;
Arnold, D T;
Dangoor, A;
Guglani, S;
Jankowska, P;
Lowndes, S A;
Harvey, J E;
Braybrooke, J P;
Maskell, N A

Publication type:

Article

Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer.

Published in:

British Journal of Cancer, 2012, v. 107, n. 1, p. 137, doi. 10.1038/bjc.2012.235

By:

Einama, T;
Homma, S;
Kamachi, H;
Kawamata, F;
Takahashi, K;
Takahashi, N;
Taniguchi, M;
Kamiyama, T;
Furukawa, H;
Matsuno, Y;
Tanaka, S;
Nishihara, H;
Taketomi, A;
Todo, S

Publication type:

Article

Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.

Published in:

2017

By:

Guntulu Ak;
Yuji Tada;
Hideaki Shimada;
Selma Metintas;
Masaaki Ito;
Kenzo Hiroshima;
Masatoshi Tagawa;
Muzaffer Metintas;
Ak, Guntulu;
Tada, Yuji;
Shimada, Hideaki;
Metintas, Selma;
Ito, Masaaki;
Hiroshima, Kenzo;
Tagawa, Masatoshi;
Metintas, Muzaffer

Publication type:

journal article

Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.

Published in:

Lung (0341-2040), 2016, v. 194, n. 3, p. 409, doi. 10.1007/s00408-016-9868-1

By:

Demir, Melike;
Kaya, Halide;
Taylan, Mahsuk;
Ekinci, Aysun;
Yılmaz, Sureyya;
Teke, Fatma;
Sezgi, Cengizhan;
Tanrikulu, Abdullah;
Meteroglu, Fatih;
Senyigit, Abdurrahman

Publication type:

Article

Serum Biomarkers in Patients with Mesothelioma and Pleural Plaques and Healthy Subjects Exposed to Naturally Occurring Asbestos.

Published in:

Lung (0341-2040), 2014, v. 192, n. 1, p. 197, doi. 10.1007/s00408-013-9526-9

By:

Bayram, Mehmet;
Dongel, Isa;
Akbaş, Ali;
Benli, İsmail;
Akkoyunlu, Muhammed;
Bakan, Nur

Publication type:

Article

Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors.

Published in:

Toxins, 2018, v. 10, n. 11, p. 447, doi. 10.3390/toxins10110447

By:

El-Behaedi, Salma;
Landsman, Rebekah;
Rudloff, Michael;
Kolyvas, Emily;
Albalawy, Rakan;
Zhang, Xianyu;
Bera, Tapan;
Collins, Keith;
Kozlov, Serguei;
Alewine, Christine

Publication type:

Article

Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.

Published in:

Toxins, 2016, v. 8, n. 8, p. 217, doi. 10.3390/toxins8080217

By:

Kaplan, Gilad;
Lee, Fred;
Onda, Masanori;
Kolyvas, Emily;
Bhardwaj, Gaurav;
Baker, David;
Pastan, Ira

Publication type:

Article

Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing.

Published in:

PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170999

By:

De Santi, Chiara;
Vencken, Sebastian;
Blake, Jonathon;
Haase, Bettina;
Benes, Vladimir;
Gemignani, Federica;
Landi, Stefano;
Greene, Catherine M.

Publication type:

Article

Immunotherapy: CAR T cell distribution centres.

Published in:

Nature Reviews Cancer, 2014, v. 14, n. 12, p. 767, doi. 10.1038/nrc3873

By:

Villanueva, Tesi

Publication type:

Article

Expression and clinical significance of Ki-67, E-cadherin, and mesothelin in serous borderline ovarian tumor.

Published in:

European Journal of Gynaecological Oncology, 2017, v. 38, n. 1, p. 85, doi. 10.12892/ejgo3479.2017

By:

Yu, N.;
Wang, N.;
Liu, Y. F.;
Li, Y. Y.;
Zhang, T. G.

Publication type:

Article

The value of mesothelin in the diagnosis and follow-up of surgically treated ovarian cancer.

Published in:

European Journal of Gynaecological Oncology, 2013, v. 34, n. 2, p. 163

By:

Qiao, Naian;
Li, Haiying

Publication type:

Article

Capture of mesothelioma cells with 'universal' CTC-chip.

Published in:

Oncology Letters, 2018, v. 15, n. 2, p. 2635, doi. 10.3892/ol.2017.7619

By:

Yoneda, Kazue;
Chikaishi, Yasuhiro;
Kuwata, Taiji;
Ohnaga, Takashi;
Tanaka, Fumihiro

Publication type:

Article

Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms.

Published in:

Oncology Letters, 2015, v. 9, n. 4, p. 1583, doi. 10.3892/ol.2015.2969

By:

TAKAHIRO EINAMA;
HIROFUMI KAMACHI;
HIROSHI NISHIHARA;
SHIGENORI HOMMA;
HIROMI KANNO;
MARIN ISHIKAWA;
FUTOSHI KAWAMATA;
YUJI KONISHI;
MASANORI SATO;
MUNENORI TAHARA;
KUNIAKI OKADA;
SHUNJI MURAOKA;
TOSHIYA KAMIYAMA;
AKINOBU TAKETOMI;
YOSHIHIRO MATSUNO;
HIROYUKI FURUKAWA;
SATORU TODO

Publication type:

Article

Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.

Published in:

Molecular & Clinical Oncology, 2013, v. 1, n. 6, p. 942, doi. 10.3892/mco.2013.175

By:

KAZUYA FUKUOKA;
KOZ KURIBAYASHI;
SHUSAI YAMADA;
KUNIHIRO TAMURA;
CHIHARU TABATA;
TAKASHI NAKANO

Publication type:

Article

Individual predictors of increased serum mesothelin in asbestos-exposed workers.

Published in:

Medical Oncology, 2013, v. 30, n. 1, p. 1, doi. 10.1007/s12032-012-0422-6

By:

Filiberti, Rosa;
Marroni, Paola;
Mencoboni, Manlio;
Mortara, Virginia;
Caruso, Pietro;
Cioè, Alex;
Michelazzi, Luigi;
Merlo, Domenico;
Bruzzone, Andrea;
Bobbio, Barbara;
Del Corso, Lisette;
Galli, Roberto;
Taveggia, Paola;
Dini, Guglielmo;
Spigno, Fabio

Publication type:

Article

Population pharmacokinetics and exposure-response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection.

Published in:

2016

By:

Gupta, Anubha;
Hussein, Ziad;
Hassan, Raffit;
Wustner, Jason;
Maltzman, Julia;
Wallin, Bruce;
Maltzman, Julia D;
Wallin, Bruce A

Publication type:

journal article

Evaluation of serum mesothelin in malignant and benign ovarian masses.

Published in:

Archives of Gynecology & Obstetrics, 2014, v. 290, n. 1, p. 107, doi. 10.1007/s00404-014-3147-2

By:

Ibrahim, Moustafa;
Bahaa, Ahmed;
Ibrahim, Ahmed;
Hakem, Amira;
Abo-El Noor, Ayman;
Tohamy, Usama

Publication type:

Article

Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.

Published in:

Archives of Gynecology & Obstetrics, 2014, v. 289, n. 6, p. 1309, doi. 10.1007/s00404-013-3128-x

By:

Wu, Xiaohua;
Li, Dongxiu;
Liu, Liping;
Liu, Bojun;
Liang, Hongxia;
Yang, Bo

Publication type:

Article

Cancer: Altered T cells hit pancreatic cancer.

Published in:: Nature, 2015, v. 527, n. 7576, p. 11, doi. 10.1038/527011a
Publication type:: Article

A PREDICTIVE CLINICAL MARKERS TO MAKE PROSTATE CANCER AND BENIGN PROSTATE HYPERPLASIA EASY DIAGNOSIS.

Published in:

Biochemical & Cellular Archives, 2021, v. 21, n. 2, p. 2939

By:

Mohammed Al-Fartosy, Adnan Jassim;
Ati, Mohammed Hammad

Publication type:

Article

Newly established ELISA for N- ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma.

Published in:

Cancer Medicine, 2014, v. 3, n. 5, p. 1377, doi. 10.1002/cam4.297

By:

Sato, Tadashi;
Suzuki, Yohei;
Mori, Takanori;
Maeda, Masahiro;
Abe, Masaaki;
Hino, Okio;
Takahashi, Kazuhisa

Publication type:

Article

Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0314-2

By:

Zervos, Emmanuel;
Agle, Steven;
Freistaedter, Andrew G.;
Jones, Gwendolyn J. B.;
Roper, Rachel L.

Publication type:

Article

Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding.

Published in:

PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197029

By:

Sirois, Allison R.;
Deny, Daniela A.;
Baierl, Samantha R.;
George, Katia S.;
Moore, Sarah J.

Publication type:

Article

Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.

Published in:

PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193131

By:

White, Michael;
Freistaedter, Andrew;
Jones, Gwendolyn J. B.;
Zervos, Emmanuel;
Roper, Rachel L.

Publication type:

Article

Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

Published in:

PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186137

By:

Alfaleh, Mohamed A.;
Howard, Christopher B.;
Sedliarou, Ilya;
Jones, Martina L.;
Gudhka, Reema;
Vanegas, Natasha;
Weiss, Jocelyn;
Suurbach, Julia H.;
de Bakker, Christopher J.;
Milne, Michael R.;
Rumballe, Bree A.;
MacDiarmid, Jennifer A.;
Brahmbhatt, Himanshu;
Mahler, Stephen M.

Publication type:

Article